These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 23946347)
1. Extracted oat and barley β-glucans do not affect cholesterol metabolism in young healthy adults. Ibrügger S; Kristensen M; Poulsen MW; Mikkelsen MS; Ejsing J; Jespersen BM; Dragsted LO; Engelsen SB; Bügel S J Nutr; 2013 Oct; 143(10):1579-85. PubMed ID: 23946347 [TBL] [Abstract][Full Text] [Related]
2. High-Molecular-Weight β-Glucan Decreases Serum Cholesterol Differentially Based on the CYP7A1 rs3808607 Polymorphism in Mildly Hypercholesterolemic Adults. Wang Y; Harding SV; Eck P; Thandapilly SJ; Gamel TH; Abdel-Aal el-SM; Crow GH; Tosh SM; Jones PJ; Ames NP J Nutr; 2016 Apr; 146(4):720-7. PubMed ID: 26936139 [TBL] [Abstract][Full Text] [Related]
3. Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Queenan KM; Stewart ML; Smith KN; Thomas W; Fulcher RG; Slavin JL Nutr J; 2007 Mar; 6():6. PubMed ID: 17386092 [TBL] [Abstract][Full Text] [Related]
4. Physicochemical properties of oat β-glucan influence its ability to reduce serum LDL cholesterol in humans: a randomized clinical trial. Wolever TM; Tosh SM; Gibbs AL; Brand-Miller J; Duncan AM; Hart V; Lamarche B; Thomson BA; Duss R; Wood PJ Am J Clin Nutr; 2010 Oct; 92(4):723-32. PubMed ID: 20660224 [TBL] [Abstract][Full Text] [Related]
5. The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials. Ho HV; Sievenpiper JL; Zurbau A; Blanco Mejia S; Jovanovski E; Au-Yeung F; Jenkins AL; Vuksan V Br J Nutr; 2016 Oct; 116(8):1369-1382. PubMed ID: 27724985 [TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of the effect of β-glucan intake on blood cholesterol and glucose levels. Tiwari U; Cummins E Nutrition; 2011 Oct; 27(10):1008-16. PubMed ID: 21470820 [TBL] [Abstract][Full Text] [Related]
7. Cholesterol-lowering effects of oat β-glucan: a meta-analysis of randomized controlled trials. Whitehead A; Beck EJ; Tosh S; Wolever TM Am J Clin Nutr; 2014 Dec; 100(6):1413-21. PubMed ID: 25411276 [TBL] [Abstract][Full Text] [Related]
8. Oat beta-glucan increases bile acid excretion and a fiber-rich barley fraction increases cholesterol excretion in ileostomy subjects. Lia A; Hallmans G; Sandberg AS; Sundberg B; Aman P; Andersson H Am J Clin Nutr; 1995 Dec; 62(6):1245-51. PubMed ID: 7491888 [TBL] [Abstract][Full Text] [Related]
9. Barley beta-glucan lowers serum cholesterol based on the up-regulation of cholesterol 7alpha-hydroxylase activity and mRNA abundance in cholesterol-fed rats. Yang JL; Kim YH; Lee HS; Lee MS; Moon YK J Nutr Sci Vitaminol (Tokyo); 2003 Dec; 49(6):381-7. PubMed ID: 14974727 [TBL] [Abstract][Full Text] [Related]
10. Serum lipids and postprandial glucose and insulin levels in hyperlipidemic subjects after consumption of an oat beta-glucan-containing ready meal. Biörklund M; Holm J; Onning G Ann Nutr Metab; 2008; 52(2):83-90. PubMed ID: 18334815 [TBL] [Abstract][Full Text] [Related]
12. Barley β-glucan reduces blood cholesterol levels via interrupting bile acid metabolism. Wang Y; Harding SV; Thandapilly SJ; Tosh SM; Jones PJH; Ames NP Br J Nutr; 2017 Nov; 118(10):822-829. PubMed ID: 29115200 [TBL] [Abstract][Full Text] [Related]
13. Oat β-glucan: physico-chemical characteristics in relation to its blood-glucose and cholesterol-lowering properties. Wang Q; Ellis PR Br J Nutr; 2014 Oct; 112 Suppl 2():S4-S13. PubMed ID: 25267243 [TBL] [Abstract][Full Text] [Related]
14. Effects of barley and oat β-glucan structures on their rheological and thermal characteristics. Ryu JH; Lee S; You S; Shim JH; Yoo SH Carbohydr Polym; 2012 Aug; 89(4):1238-43. PubMed ID: 24750937 [TBL] [Abstract][Full Text] [Related]
15. Effect of high beta-glucan barley on serum cholesterol concentrations and visceral fat area in Japanese men--a randomized, double-blinded, placebo-controlled trial. Shimizu C; Kihara M; Aoe S; Araki S; Ito K; Hayashi K; Watari J; Sakata Y; Ikegami S Plant Foods Hum Nutr; 2008 Mar; 63(1):21-5. PubMed ID: 18074229 [TBL] [Abstract][Full Text] [Related]
16. Effect of natural flocculants on purity and properties of β-glucan extracted from barley and oat. Kurek MA; Karp S; Stelmasiak A; Pieczykolan E; Juszczyk K; Rieder A Carbohydr Polym; 2018 May; 188():60-67. PubMed ID: 29525172 [TBL] [Abstract][Full Text] [Related]
17. Beta-glucan fractions from barley and oats are similarly antiatherogenic in hypercholesterolemic Syrian golden hamsters. Delaney B; Nicolosi RJ; Wilson TA; Carlson T; Frazer S; Zheng GH; Hess R; Ostergren K; Haworth J; Knutson N J Nutr; 2003 Feb; 133(2):468-75. PubMed ID: 12566485 [TBL] [Abstract][Full Text] [Related]
18. An Oat β-Glucan Beverage Reduces LDL Cholesterol and Cardiovascular Disease Risk in Men and Women with Borderline High Cholesterol: A Double-Blind, Randomized, Controlled Clinical Trial. Ms Wolever T; Rahn M; Dioum E; Spruill SE; Ezatagha A; Campbell JE; Jenkins AL; Chu Y J Nutr; 2021 Sep; 151(9):2655-2666. PubMed ID: 34236436 [TBL] [Abstract][Full Text] [Related]
19. Physicochemical and hypocholesterolemic characterization of oxidized oat beta-glucan. Park SY; Bae IY; Lee S; Lee HG J Agric Food Chem; 2009 Jan; 57(2):439-43. PubMed ID: 19119839 [TBL] [Abstract][Full Text] [Related]
20. Effects of Oat Beta-Glucan Intake on Lipid Profiles in Hypercholesterolemic Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Yu J; Xia J; Yang C; Pan D; Xu D; Sun G; Xia H Nutrients; 2022 May; 14(10):. PubMed ID: 35631184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]